Benefits and harms of long-term anticoagulant therapy (In) after acute pulmonary
Benefits and harms of long-term anticoagulant therapy (In) after acute pulmonary embolism (PE) are poorly known. fatality price for recurrence was 38.2%. In the subgroup of individuals with unprovoked PE, the opportunity of dying was considerably lower (RR 0.35; 95% self-confidence period 0.24C0.53) as well as the propensity to fatal recurrence (not significantly) better (0.11?events/100 … [Read more…]